行情

ATRS

ATRS

安塔尔制药
NASDAQ

实时行情|Nasdaq Last Sale

4.240
+0.050
+1.19%
已收盘, 18:01 01/22 EST
开盘
4.220
昨收
4.190
最高
4.320
最低
4.210
成交量
87.97万
成交额
--
52周最高
5.13
52周最低
2.600
市值
6.92亿
市盈率(TTM)
-1284.8485
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ATRS 新闻

  • Is Antares Pharma, Inc.'s (NASDAQ:ATRS) CEO Paid At A Competitive Rate?
  • Simply Wall St..6天前
  • Why Antares Pharma's Sliding 10% Today
  • MotleyFool.com.01/02 21:55
  • Here is What Hedge Funds Think About Antares Pharma Inc (NASDAQ:ATRS)
  • Insider Monkey.2019/12/14 22:20
  • Idorsia: Still As Majestic As The Swiss Alps With The Impressive Drug Pipeline It Offers Investors
  • Seeking Alpha - Article.2019/12/12 04:33

更多

所属板块

医疗设备、用品及经销
+0.94%
医疗设备和用品
+0.76%

热门股票

名称
价格
涨跌幅

ATRS 简况

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The Company's subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Vision reusable needle-free injectors and disposable multi-use pen injectors. The Company operates through drug delivery segment, which includes self-administered parenteral pharmaceutical products and technologies. The Company has developed OTREXUP (methotrexate) injection, which is a single dose, disposable auto injector.
展开

Webull提供Antares Pharma Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。